1.
Akihiro Kitadate, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Daisuke Miura, Masami Takeuchi, Kosei Matsue. Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients. Haematologica 2020;105(1):e37-e40; https://doi.org/10.3324/haematol.2019.219683.